ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,038Medicare Part D Prescriptions Filled, Including Refills

Rank: 270 out of 3734

$787K Total Retail Price of All Prescriptions

Rank: 232 out of 3734

553 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 553 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 553 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 8,426 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 562 333 1 1
OMEPRAZOLE 504 302 2 4
AMLODIPINE BESYLATE 415 316 3 5
LISINOPRIL 348 249 4 3
LEVOTHYROXINE SODIUM 332 247 5 2
FUROSEMIDE 316 243 6 7
HYDROCHLOROTHIAZIDE 286 194 7 9
CRESTOR 234 169 8 28
METFORMIN HCL 232 171 9 8
ATENOLOL 230 160 10 13
GABAPENTIN 223 114 11 17
PRAVASTATIN SODIUM 208 155 12 15
METOPROLOL TARTRATE 206 183 13 6
ADVAIR DISKUS 200 150 14 35
CITALOPRAM HBR 187 99 15 16
SPIRIVA 175 129 16 40
FLUTICASONE PROPIONATE 166 100 17 46
METOPROLOL SUCCINATE 161 101 18 14
CLOPIDOGREL 145 107 19 23
GLIMEPIRIDE 144 90 20 37
GLIPIZIDE 132 71 21 57
ALENDRONATE SODIUM 126 98 22 26
FENTANYL 122 29 S2 23 65
PLAVIX 121 90 24 39
SERTRALINE HCL 119 89 25 18
POLYETHYLENE GLYCOL 3350 115 91 26 53
WARFARIN SODIUM 110 82 27 10
ALLOPURINOL 109 68 28 33
POTASSIUM CHLORIDE 108 95 29 19
PROAIR HFA 106 70 30 83
PANTOPRAZOLE SODIUM 105 75 31 22
ZETIA 104 71 32 55
OXYCODONE-ACETAMINOPHEN 101 40 S2 33 51
ATORVASTATIN CALCIUM 101 76 33 11
RANITIDINE HCL 99 28 35 32
VENLAFAXINE HCL ER 99 54 35 84
CYMBALTA 98 46 37 67
KLOR-CON M20 96 74 38 48
HYDROCODONE-ACETAMINOPHEN 94 40 S3 39 12
JANUVIA 93 69 40 50
OXYCODONE HCL 93 46 S2 40 58
QUINAPRIL HCL 89 63 42 74
LOSARTAN POTASSIUM 88 69 43 21
DOXAZOSIN MESYLATE 85 62 44 100
AMITRIPTYLINE HCL 85 23 R 44 94
PREDNISONE 84 53 46 42
FLUOXETINE HCL 84 51 46 61
MECLIZINE HCL 83 44 48 139
LANTUS 82 53 49 54
VENTOLIN HFA 77 42 50 70
TAMSULOSIN HCL 76 68 51 29
TOPIRAMATE 75 27 52 181
TRAMADOL HCL 73 43 53 20
FINASTERIDE 73 72 53 88
RISPERIDONE 71 26 55 62
SINGULAIR 70 23 56 95
INSULIN SYRINGE 69 56 57 109
HYDRALAZINE HCL 68 55 58 111
DIGOXIN 65 65 59 43
ISOSORBIDE MONONITRATE ER 62 53 60 34
LEVOFLOXACIN 60 39 61 116
DONEPEZIL HCL 60 60 61 25
DICYCLOMINE HCL 57 20 63 248
QUETIAPINE FUMARATE 53 21 64 82
NEXIUM 52 47 65 36
GEMFIBROZIL 52 37 65 114
ESCITALOPRAM OXALATE 52 31 65 68
NITROSTAT 51 38 68 237
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.